BACKGROUND: While coiling is considered the standard treatment for carotid-cavernous fistulas (CCFs), studies demonstrating excellent results using new materials, especially flow diverter (FD) stents and liquid embolisates, are becoming more frequent. The indications and effectiveness of these alternative endovascular techniques remain unclear. METHODS: A total of 22 direct and 20 indirect CCFs were included in the study. These were further subdivided based on the embolic material used: coils versus FD stents for direct and coils versus liquid embolisates for indirect CCFs. The subgroups were subjected to statistical analysis. RESULTS: An angiographic cure was achieved in 88% of all CCFs, 93% of patients' experienced clinical improvement or remained stable. Direct CCFs were treated with coiling (41%) or with both coils and FD stents (55%). One (4%) patient with a direct CCF was treated with FD stent alone. Statistical analysis comparing these subgroups revealed a significantly higher complete occlusion rate immediately after treatment in the coiling subgroup (67% vs. 23%, p = 0.0409). The occlusion rates at the last follow-up were similar (89% vs. 85%). Indirect CCFs were treated with coiling (35%) or liquid embolisates (65%). All three periprocedural ischemic complications were recorded within the liquid subgroup, resulting in a significantly higher clinical deterioration rate (p = 0.0333). CONCLUSION: FD stents in direct and liquid embolisates in indirect fistulas did not demonstrate better angiographic or clinical outcomes compared to convetional coiling. Liquid agents carried a higher risk of ischemic complications. Alternative embolization materials should be reserved for CCFs that cannot be treated with simple coiling.

Department of Neurosurgery and Neurooncology Military University Hospital Charles University 1st Faculty of Medicine Prague Prague Czech Republic

Department of Radiology Military University Hospital Prague Czech Republic

Zobrazit více v PubMed

Barrow DL, Spector RH, Landman JA, et al. Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg 1985; 62: 248–256. PubMed

d’Angelo VA, Monte V, Scialfa G, et al. Intracerebral venous hemorrhage in “high-risk” carotid-cavernous fistula. Surg Neurol 1988; 30: 387–390. PubMed

Ellis JA, Goldstein H, Connolly ES, Jr, et al. Carotid-cavernous fistulas. Neurosurg Focus 2012; 32: E9. PubMed

Lang M, Habboub G, Mullin JP, et al. A brief history of carotid-cavernous fistula. J Neurosurg 2016; 126: 1995–2001. PubMed

Serbinenko FA. Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg 1974; 41: 125–145. PubMed

Travers B. A case of aneurism by anastomosis in the orbit, cured by the ligature of the common carotid artery. Med Chir Trans 1811; 2: 1–420. PubMed PMC

Pan DHC, Wu HM, Kuo YH, et al. Intracranial dural arteriovenous fistulas: natural history and rationale for treatment with stereotactic radiosurgery. Prog Neurol Surg 2013; 27: 176–194. doi:10.1159/000341793 PubMed DOI

Wu H, Pan DH, Chung W, et al. Gamma knife surgery for the management of intracranial dural arteriovenous fistulas. J Neurosurg 2006; 105: 43–51. PubMed

Alexander MD, Halbach VV, Hallam DK, et al. Long-term outcomes of endovascular treatment of indirect carotid cavernous fistulae: superior efficacy, safety, and durability of transvenous coiling over other techniques. Clin Neurosurg 2019; 85: E94–E100. doi:10.1093/neuros/nyy486. PubMed DOI

Kirsch M, Henkes H, Liebig T, et al. Endovascular management of dural carotid-cavernous sinus fistulas in 141 patients. Neuroradiology 2006; 48: 486–490. doi:10.1007/s00234-006-0089-9. PubMed DOI

Ducruet AF, Albuquerque FC, Crowley RW, et al. The evolution of endovascular treatment of carotid cavernous fistulas: a single-center experience. World Neurosurg 2013; 80: 538–548. doi:10.1016/j.wneu.2013.02.033. PubMed DOI

Luo CB, Teng MMH, Chang FC, et al. Transarterial detachable coil embolization of direct carotid-cavernous fistula: immediate and long-term outcomes. J Chin Med Assoc 2013; 76: 31–36. doi:10.1016/j.jcma.2012.09.007. PubMed DOI

Baranoski JF, Ducruet AF, Przbylowski CJ, et al. Flow diverters as a scaffold for treating direct carotid cavernous fistulas. J Neurointerv Surg 2019; 11: 1136–1141. doi:10.1136/neurintsurg-2019-014731. PubMed DOI

Sumdani H, Aguilar-Salinas P, Avila MJ, et al. Carotid cavernous fistula treatment via flow diversion: a systematic review of the literature. World Neurosurg 2021; 149: e369–e377. doi:10.1016/j.wneu.2021.02.015. PubMed DOI

Pashapour A, Mohammadian R, Salehpour F, et al. Long-term endovascular treatment outcome of 46 patients with cavernous sinus dural arteriovenous fistulas presenting with ophthalmic symptoms: a non-controlled trial with clinical and angiographic follow-up. Neuroradiol Journal 2014; 27: 461–470. doi:10.15274/NRJ-2014-10079. PubMed DOI PMC

Zhang J, Lv X, Jiang C, et al. Transarterial and transvenous embolization for cavernous sinus dural arteriovenous fistulae. Interv Neuroradiol 2010; 16: 269–277. PubMed PMC

Lewis AI, Tomsick TA, Tew JM. Management of 100 consecutive direct carotid-cavernous fistulas: results of treatment with detachable balloons. Neurosurgery 1995; 36: 239–245. PubMed

Gross BA, Du R. The natural history of cerebral dural. Neurosurgery 2012; 71: 594–603. doi:10.1227/NEU.0b013e31825eabdb. PubMed DOI

Nishimuta Y, Awa R, Sugata S, et al. Long-term outcome after endovascular treatment of cavernous sinus dural arteriovenous fistula and a literature review. Acta Neurochir (Wien) 2017; 159: 2113–2122. doi:10.1007/s00701-017-3336-4. PubMed DOI

de Castro-Afonso LH, Trivelato FP, Rezende MT, et al. Transvenous embolization of dural carotid cavernous fistulas: the role of liquid embolic agents in association with coils on patient outcomes. J Neurointerv Surg 2018; 10: 456–462. doi:10.1136/neurintsurg-2017-013318. PubMed DOI

Gemmete JJ, Ansari SA, Gandhi D. Endovascular treatment of carotid cavernous fistulas. Neuroimag Clin N Am 2009; 19: 241–255. doi:10.1016/j.nic.2009.01.006. PubMed DOI

Yu Y, Huang Q, Xu Y, et al. Use of onyx for transarterial balloon-assisted embolization of traumatic carotid cavernous fistulas: a report of 23 cases. Am J Neuroradiol 2012; 33: 1305–1309. doi:10.3174/ajnr.A2977. PubMed DOI PMC

Yu Y, Li Q, Huang Q, et al. Embolization of direct carotid cavernous fistula with Onyx and coils under transarterial balloon protection. Cardiovasc Intervent Radiol 2014; 37: 679–685. doi:10.1007/s00270-013-0732-x. PubMed DOI

Wendl CM, Henkes H, Martinez Moreno R, et al. Direct carotid cavernous sinus fistulae: vessel reconstruction using flow-diverting implants. Clin Neuroradiol 2017; 27: 493–501. doi:10.1007/s00062-016-0511-6. PubMed DOI PMC

Nadarajah M, Power M, Barry B, et al. Treatment of a traumatic carotid–cavernous fistula by the sole use of a flow diverting stent. J Neurointerv Surg 2011; 4: e1–e1. doi:10.1136/neurintsurg-2011-010000. PubMed DOI

Kim DJ, Kim DI, Suh SH, et al. Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management. Am J Neuroradiol 2006; 27: 2018–2082. PubMed PMC

Voldřich R, Charvát F, Beneš V, et al. What is the most effective method to treat indirect carotid-cavernous fistula? Neurosurg Rev 2022; 46: 9. PubMed

Gross BA, Albuquerque FC, Moon K, et al. Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas. J Neurosurg 2016; 126: 1884–1893. doi:10.3171/2016.5.JNS16331. PubMed DOI

Voldřich R, Netuka D, Charvat F, et al. Long-term stability of Onyx: is there any indication for repeated angiography after dural arteriovenous fistula embolization? J Neurosurg 2022; 136: 175–184. PubMed

Xianli L, Chuhan J, Youxiang L, et al. Results and complications of transarterial embolization of intracranial dural arteriovenous fistulas using Onyx-18. J Neurosurg 2008; 109: 1083–1090. PubMed